Burden of sunbed use in France and its consequences

A new study conducted by iPRI, and published the 23thof May in the Bulletin d’Epidemiologie Hebdomadaire, evaluates the impact of sunbed use on the incidence of cutaneous melanoma in France.

With 13.4% of users in France, as reported by the Baromètre Cancer 2010 of the INPES, sunbed is estimated to cause 347 melanoma cases each year. If the survival of these melanomas caused by sunbed does not differ from other melanomas, this estimation would correspond to 76 deaths per year. Several scenarios were computed and the estimated burden figures range from 566 to 2,288 deaths over 30 years. This burden is equivalent to that of a recently banned anti-diabetic drug.

The release of this study has received important press coverage: Le Figaro, 20 Minutes, Le Monde, Auféminin.com, Slate.fr, Journal International de Médecine, La Croix

The Minister of Health, Marisol Touraine, has responded to this new study on Wednesday and has announced a strengthening of French regulation on sunbed.

Sorry, comments are closed for this post.


Founded in 2009 with the broad goal of contributing to the improvement of health in populations worldwide, the International Prevention Research Institute (iPRI) aims to increase prospects for prevention through training, education, prevention research and research into causes worldwide with a focus on low and lower-middle income countries.

iPRI strives to answer three critical questions:

  • Is it healthy?
  • Is it safe?
  • Is it beneficial?

Contact iPRI

An iPRI staff member will reply promptly